spot_img
7.1 C
London
HomeInvestors HealthBiotricity expects to post Q3 revenue growth of 22%, cashflow breakeven

Biotricity expects to post Q3 revenue growth of 22%, cashflow breakeven



Biotricity expects to post Q3 revenue growth of 22%, cashflow breakeven



Source link

latest articles

explore more

LEAVE A REPLY

Please enter your comment!
Please enter your name here